212 related articles for article (PubMed ID: 22300025)
1. Development of radioligands for the imaging of α7 nicotinic acetylcholine receptors with positron emission tomography.
Brust P; Peters D; Deuther-Conrad W
Curr Drug Targets; 2012 May; 13(5):594-601. PubMed ID: 22300025
[TBL] [Abstract][Full Text] [Related]
2. Recent development of radioligands for imaging α7 nicotinic acetylcholine receptors in the brain.
Toyohara J; Wu J; Hashimoto K
Curr Top Med Chem; 2010; 10(15):1544-57. PubMed ID: 20583992
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of new radioligands [(11)C]A-833834 and [(11)C]A-752274 for positron-emission tomography of α7-nicotinic acetylcholine receptors.
Horti AG; Ravert HT; Gao Y; Holt DP; Bunnelle WH; Schrimpf MR; Li T; Ji J; Valentine H; Scheffel U; Kuwabara H; Wong DF; Dannals RF
Nucl Med Biol; 2013 Apr; 40(3):395-402. PubMed ID: 23294899
[TBL] [Abstract][Full Text] [Related]
4. [11C]CHIBA-1001 as a novel PET ligand for alpha7 nicotinic receptors in the brain: a PET study in conscious monkeys.
Hashimoto K; Nishiyama S; Ohba H; Matsuo M; Kobashi T; Takahagi M; Iyo M; Kitashoji T; Tsukada H
PLoS One; 2008 Sep; 3(9):e3231. PubMed ID: 18800169
[TBL] [Abstract][Full Text] [Related]
5. Development of radioligands with optimized imaging properties for quantification of nicotinic acetylcholine receptors by positron emission tomography.
Horti AG; Gao Y; Kuwabara H; Dannals RF
Life Sci; 2010 Apr; 86(15-16):575-84. PubMed ID: 19303028
[TBL] [Abstract][Full Text] [Related]
6. Development of [(18)F]ASEM, a specific radiotracer for quantification of the α7-nAChR with positron-emission tomography.
Horti AG
Biochem Pharmacol; 2015 Oct; 97(4):566-575. PubMed ID: 26232729
[TBL] [Abstract][Full Text] [Related]
7. In Vitro and In Vivo Characterization of Dibenzothiophene Derivatives [
Donat CK; Hansen HH; Hansen HD; Mease RC; Horti AG; Pomper MG; L'Estrade ET; Herth MM; Peters D; Knudsen GM; Mikkelsen JD
Molecules; 2020 Mar; 25(6):. PubMed ID: 32245032
[TBL] [Abstract][Full Text] [Related]
8. Novel approaches to study the involvement of α7-nAChR in human diseases.
Palma E; Conti L; Roseti C; Limatola C
Curr Drug Targets; 2012 May; 13(5):579-86. PubMed ID: 22300023
[TBL] [Abstract][Full Text] [Related]
9. Central in vivo nicotinic acetylcholine receptor imaging agents for positron emission tomography (PET) and single photon emission computed tomography (SPECT).
Ogawa M; Tsukada H; Hatano K; Ouchi Y; Saji H; Magata Y
Biol Pharm Bull; 2009 Mar; 32(3):337-40. PubMed ID: 19252274
[TBL] [Abstract][Full Text] [Related]
10. In vivo evaluation of alpha7 nicotinic acetylcholine receptor agonists [11C]A-582941 and [11C]A-844606 in mice and conscious monkeys.
Toyohara J; Ishiwata K; Sakata M; Wu J; Nishiyama S; Tsukada H; Hashimoto K
PLoS One; 2010 Feb; 5(2):e8961. PubMed ID: 20126539
[TBL] [Abstract][Full Text] [Related]
11. Derivatives of dibenzothiophene for positron emission tomography imaging of α7-nicotinic acetylcholine receptors.
Gao Y; Kellar KJ; Yasuda RP; Tran T; Xiao Y; Dannals RF; Horti AG
J Med Chem; 2013 Oct; 56(19):7574-89. PubMed ID: 24050653
[TBL] [Abstract][Full Text] [Related]
12. Preclinical and the first clinical studies on [11C]CHIBA-1001 for mapping alpha7 nicotinic receptors by positron emission tomography.
Toyohara J; Sakata M; Wu J; Ishikawa M; Oda K; Ishii K; Iyo M; Hashimoto K; Ishiwata K
Ann Nucl Med; 2009 May; 23(3):301-9. PubMed ID: 19337782
[TBL] [Abstract][Full Text] [Related]
13. 18F-ASEM, a radiolabeled antagonist for imaging the α7-nicotinic acetylcholine receptor with PET.
Horti AG; Gao Y; Kuwabara H; Wang Y; Abazyan S; Yasuda RP; Tran T; Xiao Y; Sahibzada N; Holt DP; Kellar KJ; Pletnikov MV; Pomper MG; Wong DF; Dannals RF
J Nucl Med; 2014 Apr; 55(4):672-7. PubMed ID: 24556591
[TBL] [Abstract][Full Text] [Related]
14. Potential of α7 nicotinic acetylcholine receptor PET imaging in atherosclerosis.
Boswijk E; Bauwens M; Mottaghy FM; Wildberger JE; Bucerius J
Methods; 2017 Nov; 130():90-104. PubMed ID: 28602809
[TBL] [Abstract][Full Text] [Related]
15. Recent PET radioligands with optimal brain kinetics for imaging nicotinic acetylcholine receptors.
Horti AG; Kuwabara H; Holt DP; Dannals RF; Wong DF
J Labelled Comp Radiopharm; 2013; 56(3-4):159-66. PubMed ID: 24285321
[TBL] [Abstract][Full Text] [Related]
16. Radiochemical synthesis and in vivo evaluation of [18F]AZ11637326: an agonist probe for the α7 nicotinic acetylcholine receptor.
Ravert HT; Dorff P; Foss CA; Mease RC; Fan H; Holmquist CR; Phillips E; McCarthy DJ; Heys JR; Holt DP; Wang Y; Endres CJ; Dannals RF; Pomper MG
Nucl Med Biol; 2013 Aug; 40(6):731-9. PubMed ID: 23680470
[TBL] [Abstract][Full Text] [Related]
17. The quest for Eldorado: development of radioligands for in vivo imaging of nicotinic acetylcholine receptors in human brain.
Horti AG; Villemagne VL
Curr Pharm Des; 2006; 12(30):3877-900. PubMed ID: 17073685
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of [125I]I-TSA as a brain nicotinic acetylcholine receptor alpha7 subtype imaging agent.
Ogawa M; Tatsumi R; Fujio M; Katayama J; Magata Y
Nucl Med Biol; 2006 Apr; 33(3):311-6. PubMed ID: 16631079
[TBL] [Abstract][Full Text] [Related]
19. PET imaging evaluation of [(18)F]DBT-10, a novel radioligand specific to α7 nicotinic acetylcholine receptors, in nonhuman primates.
Hillmer AT; Zheng MQ; Li S; Scheunemann M; Lin SF; Holden D; Labaree D; Ropchan J; Teodoro R; Deuther-Conrad W; Carson RE; Brust P; Huang Y
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):537-47. PubMed ID: 26455500
[TBL] [Abstract][Full Text] [Related]
20. Assessment of α7 nicotinic acetylcholine receptor availability in juvenile pig brain with [¹⁸F]NS10743.
Deuther-Conrad W; Fischer S; Hiller A; Becker G; Cumming P; Xiong G; Funke U; Sabri O; Peters D; Brust P
Eur J Nucl Med Mol Imaging; 2011 Aug; 38(8):1541-9. PubMed ID: 21484373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
